The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2013

Filed:

Feb. 04, 2011
Applicants:

Arthur B. Raitano, Los Alamitos, CA (US);

Mary Faris, Los Angeles, CA (US);

Pia M. Challita-eid, Encino, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Wangmao GE, Los Angeles, CA (US);

Inventors:

Arthur B. Raitano, Los Alamitos, CA (US);

Mary Faris, Los Angeles, CA (US);

Pia M. Challita-Eid, Encino, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Wangmao Ge, Los Angeles, CA (US);

Assignee:

Agensys, Inc., Santa Monica, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C12N 15/00 (2006.01); C12N 1/20 (2006.01); C12P 21/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel gene 202P5A5 and its encoded protein, and variants thereof, are described wherein 202P5A5 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 202P5A5 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 202P5A5 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 can be used in active or passive immunization.


Find Patent Forward Citations

Loading…